Logo-npj

Mini-Review

1. Glucose transporters in kidney; the role of gender and diabetes mellitus

Fatemeh Kharazmi ORCID, Hajaralsadat Hosseini Dastgerdi ORCID, Shadan Saberi ORCID, Maryam Maleki ORCID, Nepton Soltani ORCID, Mehdi Nematbakhsh* ORCID
J Nephropharmacol. 2022;11(1): e3. doi: 10.34172/npj.2022.03
Scopus ID: 85119584500    
Article
PDF
XML
Cited By:
0
0

News and Views

2. Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy
Samaneh Zandifar ORCID, Shokouh Shayanpour* ORCID
J Nephropharmacol. 2023;12(2): e10606. doi: 10.34172/npj.2023.10606
Scopus ID: 85161967933    
Article
PDF
XML
Cited By:
0
0
Meta Analysis

3. The association between the utilization of SGLT2 inhibitors and diabetic retinopathy; a systematic review and meta-analysis of cohort studies
Shahriar Barkhordari ORCID, Shahrzad Ghaffariyan ORCID, Farzin Banei ORCID, Mohammad Shirvani ORCID, Farangis yazdanjou ORCID, Sara Ghaseminejad Kermani ORCID, Mohammad Akbari ORCID, Alireza Baghaei ORCID, Mobin Mohammadtabar* ORCID
J Nephropharmacol. 2024;13(2): e12688. doi: 10.34172/npj.2024.12688
Article
PDF
XML
Cited By:
0
Meta Analysis

4. Association between triglyceride-glucose index and risk of chronic kidney disease: a systematic review and meta-analysis
Muhanad Muhussin Ali ORCID, Raed Muslim Mhaibes* ORCID, Mohammed Abdul-Mounther Othman ORCID, Qais R. Lahhob ORCID, Mohammed Jasim Qasim
J Nephropharmacol. 2024;13(2): e12692. doi: 10.34172/npj.2024.12692
Article
PDF
XML
Cited By:
0
Original

5. Protective effects of bexagliflozin on renal function in a rat model of ischemia-reperfusion injury; an experimental animal study
Ghada A. Alkhafaji ORCID, Ali M. Janabi* ORCID
J Nephropharmacol. 2025;. doi: 10.34172/npj.2025.12760
Article
PDF
XML
Cited By: